欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号MT/H/0609/002
药品名称Rabeprazole Aurobindo Tablets Gastro-Resistant 20mg
活性成分
    • Rabeprazole sodium salt 20.0 mg
剂型Gastro-resistant tablet
上市许可持有人Aurobindo Pharma (Malta) Limited Vault 14, Level 2 Valletta Waterfront Valletta FRN 1913 Malta
参考成员国 - 产品名称Malta (MT)
Rabeprazole Aurobindo Tablets Gastro-Resistant 20mg
互认成员国 - 产品名称
    许可日期2012/06/21
    最近更新日期2024/09/27
    药物ATC编码
      • A02BC04 rabeprazole
    申请类型
    • TypeLevel1:[not specified]
    • TypeLevel2:[not specified]
    • TypeLevel3:[not specified]
    • TypeLevel4:[not specified]
    • TypeLevel5:[not specified]
    附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase